InvestorsHub Logo
Followers 3
Posts 1678
Boards Moderated 0
Alias Born 12/23/2011

Re: I-Man post# 589

Tuesday, 03/26/2019 8:23:53 AM

Tuesday, March 26, 2019 8:23:53 AM

Post# of 1471
This article highlights the problem with the device (without actually mentioning it). The cost was not covered by insurance, they had to raise the money via fundraising. Not everyone who could benefit from the device can raise the funds.

I believe a major difference between RWLK and EKSO is that EKSO is not solely concerned with just getting a person "walking" (where the device does all the work). They are focusing on rehabilitating the patients so they can eventually walk with less help from the device or completely on their own.

While getting a person upright and standing at eye level has physical and emotional benefits, the device is much too expensive to basically make the wearer just a passenger. (which is what I feel RWLK is doing)

The new device (ReStore) is less expensive, and will aid patients who can already walk with some other device. While it is a less expensive device, that means they must find more customers.

I really do not think the ReStore device is enough to save this company and keep it afloat until they develop new and more advanced products.

While ReStore may be a good product, technology and competition is constantly evolving and making previous devices obsolete. It is my opinion that RWLK as managed currently cannot keep up. They will continue to need more funding for improvements or outright new devices or technologies, never being profitable.



Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent RWLK News